Long-term impact of gestational and early-life dietary habits on infant gut immunity and disease risk
|Partner Organization||Partner Country|
|IPLESP INSERM UPMC||France|
|Department for Microbiology and Systems Biology (TNO)||The Netherlands|
|TecnATox, Universitat Rovira i Virgili (URV), Tarragona||Spain|
|Pulmonary Environmental Epidemiology Unit (EPAP), CNR Institute of Clinical Physiology, Pisa (Italy) (CNR)||Italy|
1. Overall project description
Man is colonized immediately upon birth by environmental microbes of primarily maternal origin. Initial colonization and transfer of maternal immunity through breastfeeding are believed to impact infant health at short- and long-term by conferring protection from infection and potentially resistance to metabolic and allergic diseases.
Our objectives are to assess the importance of dietary habits on neonatal colonization and gut immunity. To attain these goals, we will analyze meconium samples from formula- versus breastfed children. Our analysis includes microbiome composition, secretory-IgA immune-microbiome and (xeno)-metabolomics. In vitro studies will define the impact of selected metabolites on gut microbiota composition and validate by comparison with ex vivo data linking metabolites and microbiota composition. Finally, integrative exposome analysis will combine experimental and epidemiological data to provide associations with life style and clinical outcome.
Presently, partner UPMC has provided access to meconium samples from 60 children stratified for allergic outcome and breastfeeding (EDEN cohort). Partner UPMC has equally recruited 600 mother-child couples (EXHES), for which we have obtained 230 meconium samples. The meconium samples have been processed by partner CIMI to extract microbes (metagenomic and immune-metagenomic analysis) and fecal water (metabolomics analysis). Ex vivo analysis of the fraction of microbes bound by immunoglobulins have been effectuated The microbiota composition and Immuno-microbiome analysis of this cohort is in progress by partner CIMI. Partner TNO has conducted extensive metabolomics analysis of fecal water samples. Partner URV has acquired 20 paired breastmilk and meconium samples and CNR has obtained 27 longitudinal meconium samples from twins. The URV samples have been analyzed for xenometabolites, which will be used to validate a Physiologically based pharmacokinetic (PBPK) model describing transfer of xenometabolites from mother to child through breastfeeding. The samples from URV and CNR have been send to Paris (Partners CIMI and UPMC). Aliquotes and shipment of samples to other partners is in progress (temporarily halted by the COVID-19 epidemics).
The program will identify predictive biomarkers and early-life preventive strategies for the growing epidemic of human metabolic and allergic diseases. Such advances may have important impact on public health and generate socio-economic benefits.
The EarlyFOOD consortium has recruited more than 200 mother-child couples for whom we have infant fecal samples. These fecal samples will be analysed for microbial composition and anti-microbial immunity as well as metabolite content. Associated with dietary and epidemiological data we expect to identify dietary influences on key biological and clinical parameters, which could pave the way for new mechanistic studies and guide political decision making.
4.1 List of publications
|Authors||Title||Year, Issue, PP||Partners Number||Doi|
4.2 Presentation of the project
|Target group||Authors||Means of communication||Hyperlink|
|Scientists and medical doctors||Partner CIMI : 13eme Congres Francophone d’Allergologie (CFA 2018, Paris, France). Invited speaker: “Microbiome et allergies : du petit au grand”, Larsen M (18.04.18)||Powerpoint|
|Scientists and medical doctors||Partner CIMI : 14eme Congres Francophone de Allergologie (CFA 2019, Paris, France). Invited speaker: “Microbiome et allergies”, Larsen M (17.04.19)||Powerpoint|
|Scientists||Partner CIMI : 2nd Summer School on Microbiome in Health and Disease - from populations to models (Seeon, Germany). Invited speaker: “Infant microbiome – early life IgA response”, Larsen M (28.06.19)||Powerpoint|
|Citizens, students, institutional and industry representatives, researchers, foundations, associations.||Partner CNR : Sara Maio, Sandra Baldacci (Drs.); title of the presentation "New approaches in assessing the effects of the environmental exposure", within the "Convention for the 50th anniversary of the foundation of the CNR Institute of Clinical Physiology"; Pisa (Italy), April 4, 2019||Powerpoint|
|Students, scientists||Partner URV : Authors: M. A. Martínez J. Rovira, R. Prasad Sharma, M. Nadal, M. Schuhmacher, V. Kumar Title: How much do dietary and non-dietary sources contribute to prenatal exposure to BPA and DEHP? A Catalonia (Spain) case study. Conference: 15th Doctoral Day Organizer Entity: Rovira I Virgily (Tarragona, Spain, 2018)||Platform|
|Students, scientists||Partner URV: Authors: M. A. Martínez J. Rovira, R. Prasad Sharma, M. Nadal, M. Schuhmacher, V. Kumar Title: Dietary and non-dietary prenatal exposure to endocrine disruptors (BPA and DEHP). Spanish case study. EUROTOX- 54th Congress of the European Societies of Toxicology (Brussels, Belgium, 2018)||Poster|
|Students, scientists||Partner URV: Authors: Deepika Deepika, Raju Prasad Sharma, M Schuhmacher, Vikas Kumar. Title: Development of Brain Sub-compartment PBPK model for PFASs chemicals to assess Neurotoxicity; A Case Study on Mixture Risk Assessment INA 17 (International Neurotoxicology Association) (Düsseldorf, Germany, 2019)||Poster|
|Students, Scientists||Sara Maio, Sandra Baldacci and the Pulmonary Environmental Epidemiology Unit of CNR-IFC, New approaches in the assessment of environmental exposure effects. IFC50+. A convention for the 50th anniversary of the Institute fundation. 2019||Powerpoint|
4.3 List of submitted patents and other outputs
|Patent licence||Partners involved||Year||International eu or national patent||Comment|